Elite Pharmaceuticals Inc. is actively pursuing uplisting to the Nasdaq stock exchange.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Elite Pharmaceuticals Inc. is actively pursuing uplisting to the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Generate Biomedicines Inc listed its shares on the Nasdaq exchange and received research notes and ratings from Cantor Fitzgerald.
- U.S. investor relations support Nasdaq listing pathway.
- Innovative Eyewear listed its stock on the Nasdaq exchange and saw institutional investor buying activity on August 16, 2026.
- Iovance Biotherapeutics listed its stock on Nasdaq and received Fast Track designation from the FDA.
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.